Interesting article about Dendreon - George...

Interesting article about Dendreon - George Soros

http://seekingalpha.com/article/269523-7-lesser-known-george-soros-buys?source=yahoo

Dendreon Corporation (DNDN) is Soros' last stock to be analyzed. Soros more than doubled his existing shares in the company in the reporting period ending 12/31, adding over four million shares to his portfolio. Dendreon Corporation is a biotechnology firm focused on the discovery, development, and commercialization of novel cancer therapies. The reason Soros Fund Management added shares is likely because the Centers for Medicare & Medicaid Services announced recently that it would support reimbursement for Provenge, the first "cancer vaccine." Provenge, an expensive prostate cancer therapy, prolongs patients' lives by a median of four months, and was deemed to be superior enough to existing alternatives that Medicare decided to pay $93,000 for each course of the therapy.

The drug already looked like a potential blockbuster, but the recent news only increases its potential market and likelihood of becoming a moneymaking machine. The drug faces one last regulatory hurdle, but is expected to pass it this summer. Expect larger pharmaceutical companies to come sniffing around once it does.